Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19.

导出 OA

翻译打印收藏纠错

第一作者： Maria,Ormhøj

第一单位： Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.;Department of Clinical Immunology, Odense University Hospital, University of Southern Denmark, Odense, Denmark.

作者： Maria,Ormhøj ^[1] ; Irene,Scarfò ^[2] ; Maria L,Cabral ^[2] ; Stefanie R,Bailey ^[2] ; Selena J,Lorrey ^[2] ; Amanda A,Bouffard ^[2] ; Ana P,Castano ^[2] ; Rebecca C,Larson ^[2] ; Lauren S,Riley ^[2] ; Andrea,Schmidts ^[2] ; Bryan D,Choi ^[2] ; Rikke S,Andersen ^[3] ; Oriane,Cédile ^[4] ; Charlotte G,Nyvold ^[4] ; Jacob H,Christensen ^[5] ; Morten F,Gjerstorff ^[6] ; Henrik J,Ditzel ^[6] ; David M,Weinstock ^[7] ; Torben,Barington ^[8] ; Matthew J,Frigault ^[9] ; Marcela V,Maus ^[10]

作者单位： Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.;Department of Clinical Immunology, Odense University Hospital, University of Southern Denmark, Odense, Denmark. ^[1] Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. ^[2] Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark. ^[3] Haematology-Pathology Research Laboratory, Odense University Hospital, University of Southern Denmark, Odense, Denmark.;Department of Pathology, Odense University Hospital, Odense, Denmark.;OPEN, Odense Patient Data Explorative Network, Odense University Hospital, Odense, Denmark. ^[4] Department of Haematology, Odense University Hospital, University of Southern Denmark, Odense, Denmark. ^[5] Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.;Department of Oncology, Odense University Hospital, Odense, Denmark. ^[6] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Harvard Medical School, Boston, Massachusetts. ^[7] Department of Clinical Immunology, Odense University Hospital, University of Southern Denmark, Odense, Denmark.;OPEN, Odense Patient Data Explorative Network, Odense University Hospital, Odense, Denmark. ^[8] Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.;Harvard Medical School, Boston, Massachusetts. ^[9] Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts. mvmaus@mgh.harvard.edu.;Harvard Medical School, Boston, Massachusetts. ^[10]